Source: International Congress 2017 – TB: co-morbidities and outcome
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
P. Ankale (Mumbai (Maharashtra), India). Socioeconomic Conditions Contributing to Multi Drug Resistant (MDR) and Extremely Drug Resistant(XDR) Tuberculosis. 2727

Member's Comments

No comment yet.

Related content which might interest you: Nature, Magnitude and Risk Factors of Adverse Drug Reactions in Multidrug Resistant TB Patients in Eritrea Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018 Evaluation of 123 Cases with MDR TB (Multidrug Resistant Tuberculosis) Treatment Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018 Socioeconomic Status and Cleaning: Major Factors Affecting Asthma Control Source: Virtual Congress 2020 – Clinical and functional evaluation of asthmatics Year: 2020 Results of the 2003–2004 TB Drug Resistance Survey in Romania Source: Eur Respir J 2006; 28: Suppl. 50, 457s Year: 2006 Psychiatric Complications in Patients Receiving Treatment for Multi-Drug Resistant Tuberculosis Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations Year: 2020 Meta-analysis on the Effect of Current Smoking on the Risk of Developing Community Acquired Pneumonia Source: International Congress 2018 – Systematic reviews on the health effects of emerging tobacco products and electronic nicotine delivery systems (ENDS) Year: 2018 Clinical Features Associated with Linezolid Resistance Among Multidrug Resistant Tuberculosis Patients at a Tertiary Care Hospital in Mumbai, India Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 Understanding of Pharmacokinetics and Exposure Drives use of Nintedanib as a Positive Control Reference Item in a Rat Model of Bleomycin-Induced Fibrosis Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 Short-term Impact of Lung Flute and Inspiratory Muscle Trainer on Pulmonary Functions and Functional Capacity in COPD from a Low Middle Income Country : A Pilot Randomized Control Trial. Source: Virtual Congress 2020 – New insights into respiratory physiotherapy Year: 2020 A Study on Various Types of Presentations of Paediatric Tuberculosis and Response to  Fixed Dose Combination (FDC). Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis Year: 2020 Evaluation of concurrent use of Tobacco products (Water Pipe and Cigarettes) and Associated Factors in Adults in Tehran Source: International Congress 2017 – Global epidemiologic data on smoking Year: 2017 Prevalence of Latent Infection with Mycobacterium Tuberculosis in Interstitial Lung Diseases Using Interferon Gamma Release Assay Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017 Late Breaking Abstract - Does The High Use Of Oral Antiasthmatics Contribute To The Elevated Burden Of Asthma In India? Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019 Recombinant Tuberculosis Allergen in Detecting Latent Tuberculosis Infection in Adults Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018 Late Breaking Abstract - Characteristics of Patients Diagnosed with Severe Asthma at UK Specialist Centres: Variation by Ethnicity Source: International Congress 2019 – Bronchiectasis Year: 2019 Multidrug Resistant Tuberculosis (MDR-TB) Source: CME Online 2010 Year: 2005 High Intensity Resistance Training Improves Respiratory, Peripheral, Quality of Life and Emotional Response in Elderly with Parkinson Disease Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases Year: 2017 Oral presentation: A New Target and Novel Agent to Prevent Acute Lung Injury Source: Lung Science Conference 2014 - Lung Inflammation and Immunity Year: 2014 Prevalence of Multidrug Resistant Tuberculosis among TB Patients in Malaysia. Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases Year: 2021 A First-in-Class PRS Inhibitor, DWN12088, as a Novel Therapeutic Agent for Systemic Sclerosis and Associated Interstitial Lung Disease Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases Year: 2021